These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of antacids on intragastric pH in healthy subjects and duodenal ulcer patients. Influence of the size of the antacid dose and of anticholinergics. Uusitalo A; Keyriläinen O Clin Physiol; 1983 Dec; 3(6):503-11. PubMed ID: 6686808 [TBL] [Abstract][Full Text] [Related]
4. [Gastrobulbar pH during combination antacid therapy in bulbar ulcers]. Dolinský A Vnitr Lek; 1978 Jun; 24(6):608-13. PubMed ID: 27899 [No Abstract] [Full Text] [Related]
5. Anticholinergics and antacids. Polish E Semin Drug Treat; 1974; 3(4):331-8. PubMed ID: 4822255 [No Abstract] [Full Text] [Related]
6. [Therapeutic effect of a new antisecretory and antacid medication]. Galli L; Bissi A Minerva Chir; 1968 May; 23(9):477-82. PubMed ID: 4386093 [No Abstract] [Full Text] [Related]
7. Drug therapy of patients treated in hospitals for duodenal ulcers. Roberts KB; Garner DD; Smith MC Am J Hosp Pharm; 1976 Dec; 33(12):1268-72. PubMed ID: 998646 [TBL] [Abstract][Full Text] [Related]
8. [Conservative treatment of gastroduodenal ulcer]. Hafter E Praxis; 1967 Feb; 56(8):266-9. PubMed ID: 6072099 [No Abstract] [Full Text] [Related]
9. [Changes in the drug therapy of ulcers]. Henning N Munch Med Wochenschr; 1968 Apr; 110(17):1049-53. PubMed ID: 5755537 [No Abstract] [Full Text] [Related]
10. [Ulcers. VI. Medical treatment]. Dotevall G; Walan A Lakartidningen; 1966 Dec; 63(50):4834-8. PubMed ID: 5977895 [No Abstract] [Full Text] [Related]
11. [Review and study of the immediate results of medical treatment of 283 patients with various esophageal-gastrointestinal processes]. Martínez Obrador D; Balanza Ortíz E Rev Esp Enferm Apar Dig; 1972 Mar; 36(6):735-52. PubMed ID: 5017112 [No Abstract] [Full Text] [Related]
12. A clinical evaluation of a new concentrated antacid. II. Safety and efficacy in duodenal ulcer patients. Powell RL; Westlake WJ; Longaker ED; Greene LC J Clin Pharmacol New Drugs; 1971; 11(4):296-300. PubMed ID: 4932746 [No Abstract] [Full Text] [Related]
13. Trials with Gaviscon: its mode of action and its use in the treatment of duodenal ulcers (a double-blind trial). Moshal MG S Afr J Surg; 1973 Sep; 11(3):139-44. PubMed ID: 4589219 [No Abstract] [Full Text] [Related]
14. [Calcium-containing antacids in the therapy of duodenal ulcers]. Weingart J; Kunert H Fortschr Med; 1981 Feb; 99(8):278-82. PubMed ID: 7274971 [TBL] [Abstract][Full Text] [Related]
15. [In vitro measurement of antacid capacity of commonly employed antacids (author's transl)]. Csendes A; Antezana C; Meneses G Rev Med Chil; 1979 Nov; 107(11):1014-21. PubMed ID: 45047 [No Abstract] [Full Text] [Related]
16. [Clinico-physiological basis for rational use of antacids in the treatment of duodenal ulcer]. Dorofeev GI; Ivashkin VT; Uspenskiĭ VM Sov Med; 1972 Aug; 35(8):7-11. PubMed ID: 5070551 [No Abstract] [Full Text] [Related]
17. [Conservative therapy of gastro-duodenal ulcers in the ambulatory general practice]. Deyhle P; Classen M Z Allgemeinmed; 1971 May; 47(15):816-7. PubMed ID: 4932607 [No Abstract] [Full Text] [Related]
19. Preliminary experience with vanamil, a new antacid. Riegel N Curr Ther Res Clin Exp; 1970 Mar; 12(3):161-9. PubMed ID: 4985495 [No Abstract] [Full Text] [Related]
20. Antacid therapy for duodenal and gastric ulcer: the experience in the United States. Ippoliti AF Scand J Gastroenterol Suppl; 1982; 75():82-5. PubMed ID: 6755655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]